Chris Welty

Chris Welty
Dr. Welty enjoys practicing general urology, including urologic oncology (bladder, prostate, kidney, testis, and penile cancer), kidney stone disease, voiding dysfunction in men and women, as well as issues relating to men’s health such as erectile dysfunction, benign prostate enlargement and low testosterone/infertility. He is fully trained in the endoscopic treatment of prostatic obstruction, stone disease, and disorders of the upper urinary tract. He is also trained in penile prostheses, vasectomy, sacral neuromodulation, artificial urinary sphincters and slings. In addition, Dr. Welty has extensive fellowship training in surgical and clinical management of urologic cancers, including Da Vinci robotic, laparoscopic, and open surgical approaches. His prior research has focused on risk stratification, management, and outcomes of prostate and bladder cancers, including several papers on how to differentiate men with prostate cancer who need treatment from those who likely do not. Dr. Welty will be practicing in our Oakland office. He believes understanding each patient’s priorities, and helping them understand their diagnosis and treatment options, is the key to developing a personalized treatment plan care. Dr. Welty also enjoys golfing, cycling, skiing, and all outdoor activities, especially with his family and his dog.
Medical School:

Vanderbilt University


University of Washington


UCSF - Urologic Oncology


Dartmouth College

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only